
Good Growth Capital
Description
Good Growth Capital is an early-stage venture capital firm based in Charleston, South Carolina, with an additional presence in Boston, Massachusetts. The firm is dedicated to investing in transformative science- and technology-based companies, primarily focusing on deep tech, life sciences, and B2B software sectors. Their investment thesis centers on identifying companies with strong intellectual property and disruptive potential, aiming to support them from Seed through Series A rounds. They seek out ventures poised to create significant market impact through scientific and technological breakthroughs.
The firm's investment strategy is characterized by its commitment to providing significant early capital to promising ventures. Good Growth Capital typically deploys initial checks ranging from $500,000 to $1.5 million, positioning them as a key early-stage investor for high-growth potential startups. As of their Fund III, which initially closed at $50 million, the firm has demonstrated a robust capacity to back innovative companies. They are active investors, having made over 80 investments to date, indicating a broad and diversified portfolio approach within their specialized sectors.
Beyond capital, Good Growth Capital emphasizes a hands-on approach, providing strategic guidance and leveraging their extensive network to help portfolio companies scale. They are known for their commitment to diversity and inclusion within their investment decisions, seeking out founders from diverse backgrounds. Their focus on science and technology-driven innovation underscores a long-term vision for impactful returns, supporting ventures that aim to solve complex problems and create new markets. The firm's geographic presence in both the burgeoning Southeast tech hub and the established Boston biotech ecosystem allows them to tap into a wide array of scientific and technological advancements.
Investor Profile
Good Growth Capital has backed more than 101 startups, with 4 new investments in the last 12 months alone. The firm has led 32 rounds, about 32% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Health Care, Biotechnology, Information Technology.
- Typical check size: $500K – $1.5M.
Stage Focus
- Seed (42%)
- Series A (24%)
- Convertible Note (21%)
- Series Unknown (10%)
- Series B (2%)
- Pre Seed (2%)
Country Focus
- United States (98%)
- France (2%)
Industry Focus
- Health Care
- Biotechnology
- Information Technology
- Medical Device
- Software
- Artificial Intelligence (Ai)
- Machine Learning
- Manufacturing
- Analytics
- Energy
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.